2015-05-11 12:20:00 UTC

AGA to Offer New Programs in IBD and HCV

May 11, 2015

AGA is dedicated to providing coordinated quality packages to help GIs improve their patient care.

AGA’s Partners in Quality Program continues to support the development and enhancement of a coordinated quality package for gastroenterologists that includes the development, revision and testing of relevant performance measures, clinical service lines, practice improvement modules and mobile applications to improve patient care.

We are pleased that Janssen Scientific Affairs, LLC, has provided support for the AGA Partners in Quality Program to enhance activities in IBD and hepatitis C quality-improvement efforts and for the AGA Roadmap to the Future of GI.

Building on AGA’s innovations in quality improvement, the relationship with Janssen Scientific Affairs, LLC, seeks to enhance clinicians' understanding of clinical quality improvement efforts and demonstrate a commitment to supporting excellence of care in the GI community, as well as the improvement of health outcomes for patients.

More on Hepatitis C

Building Foundations Among Payers & Providers for Collaborative Care in HCV & HIV

Dec. 7, 2017

In this video, leading experts in HCV, HIV, and managed care engage in a crossfire panel discussion on key challenges, considerations and solutions for improving patient management, and appropriate access to HCV and HIV therapies.

Translating Basic Science Into Clinical Application

Dec. 7, 2017

The CMGH editors summarize five recently accepted studies in four sentences or less.

Experts Update HCV Treatment and Care Guidelines

Nov. 9, 2017

Revision adds newly approved treatments and recommendations for special populations.